Since its establishment in 1997, Cambridge Biomedical has supported sponsors and CRO's developing customized assays for small and large molecules, biomarkers, diagnostics, and medical devices. Our team has expertise and extensive experience in technology transfer, assay development, optimization, and validation. We are positioned to work with you at preclinical, clinical, and post market stages of drug or device development.